Rates of Disease Progression according to Initial Highly Active Antiretroviral Therapy Regimen: A Collaborative Analysis of 12 Prospective Cohort Studies | Zendy

Robert S. Hogg | Zendy; Margaret May | Zendy; Andrew Phillips | Zendy; Dominique Costagliola | Zendy; Jonathan A C Sterne | Zendy; Caroline Sabin | Zendy; Frank de Wolf | Zendy; Bruno Ledergerber | Zendy; A. D’Arminio Monforte | Zendy; Justice Afrifa | Zendy; Jason S. Gill | Zendy; Gregory Fusco | Zendy; Schlomo Staszewski | Zendy; J Rockstroh | Zendy; Geneviève Chêne | Zendy; Matthias Egger | Zendy

Open Access

Rates of Disease Progression according to Initial Highly Active Antiretroviral Therapy Regimen: A Collaborative Analysis of 12 Prospective Cohort Studies

Author(s) -

Robert S. Hogg,

Margaret May,

Andrew Phillips,

Dominique Costagliola,

Jonathan A C Sterne,

Caroline Sabin,

Frank de Wolf,

Bruno Ledergerber,

A. D’Arminio Monforte,

Justice Afrifa,

Jason S. Gill,

Gregory Fusco,

Schlomo Staszewski,

J Rockstroh,

Geneviève Chêne,

Matthias Egger

Publication year - 2006

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/506362

Subject(s) - medicine , efavirenz , stavudine , abacavir , nelfinavir , hazard ratio , didanosine , regimen , zidovudine , lamivudine , saquinavir , ritonavir , nevirapine , reverse transcriptase inhibitor , viral load , confidence interval , immunology , viral disease , antiretroviral therapy , human immunodeficiency virus (hiv) , hepatitis b virus , virus

No large clinical end-point trials have been conducted comparing regimens among human immunodeficiency virus type 1-positive persons starting antiretroviral therapy. We examined clinical progression according to initial regimen in the Antiretroviral Therapy Cohort Collaboration, which is based on 12 European and North American cohort studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research